Seroprevalence of cytomegalovirus infection among healthy blood donors in Bahia state, Brazil;Soroprevalência da infecção por citomegalovírus entre doadores de sangue saudáveis no estado da bahia, Brasil

Revista Brasileira de Hematologia e Hemoterapia

Volumn 32, Issue 1, 2010, Pages 45-49

  Matos, Sócrates B ^a   Meyer, Roberto ^a   Lima, Fernanda W M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Blood donors; Cytomegalovirus infection; Prevalence

Indexed keywords

EID: 77952658789     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842010005000009     Document Type: Article

References (20)

1. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Micr Rev. 2009;22(1):76-98.
2. Taylor GH. Cytomegalovirus. Am Fam Phys. 2003;67(3):519-24.
3. Qu L, Tran MH. Cytomegalovirus (CMV) and transfusion medicine. Blood Bulletin. 2007;9(1).
4. Ljungman P. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction. Br J Haematol. 2004;125(2):107-16.
5. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood. 2003;101(10):4195-200.
6. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008;8:111.
7. Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr. 2002;20(4):348-51.
8. Adjei AA, Armah HB, Narter-Olaga EG. Seroprevalence of cytomegalovirus among some voluntary blood donors at the 37 Military Hospital, ACCRA, Ghana. Ghana Med J. 2006;40 (3):99-104.
9. Mutlu B, Gunlemez A, Turker G, Gokalp AS, Willke A. Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients? Mikrobiyol Bul. 2008;42(2):337-41.
10. Alao OO, Joseph DE, Mamman A, Banwat EB. The seroprevalence of cytomegalovirus antibodies among prospective blood donors in Jos. Niger J Med. 2008;17(2):198-200.
11. Gargouri J, Elleuch H, Karray H, Rekik H, Hammami A. Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med. 2000;78(8-9):512-7.
12. Boeke CE, Pauly ME, Hatch-Stock H, Jackson JB. CMV antibody prevalence and seroincidence in plateletpheresis donors. J Clin Apher. 2008;23(2):63-5.
13. Harvey J, Dennis CL. Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review. J Adv Nurs. 2008;63(5):440-50.
14. de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, et al. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res. 1998;39(3):141-62.
15. Drew WL, Roback JD. Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate? Transfusion. 2007; 47 (11):1955-8.
16. Kanengisser-Pines B, Hazan Y, Pines G, Appelman Z. High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy. J Perinat Med. 2009;37(1):15-8.
17. Cavlek TV, Sternak SL, Galinovic GM. Value of IgG avidity in cytomegalovirus infection diagnosis in pregnant women and newborn infants. Med Jad. 2008;38(1-2):23-8.
18. Kuo CP, Wu CL, Ho HT, Chen CG, Liu SI, Lu YT. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy. Clin Microbiol Infect. 2008;14(3):221-7.
19. Bonon SHA, Rossi CL, De Souza CA, Vigorito AC, Costa SCB. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients. Rev Inst Med Trop S Paulo. 2006;48(5):275-78.
20. Novak Z, Ross SA, Patro RK, Pati SK, Kumbla RA, Brice S et al. Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol. 2008;46(3):882-6.